Oscar Westin graduated from Umeå University, Sweden, in 2014. He defended his PhD dissertation on cardiac amyloidosis in early 2023 at Copenhagen University, Denmark, and began his cardiology residency shortly thereafter. He has clinical experience in patients with cardiac amyloidosis from his own screening studies and from working as a sub-investigator for the Apollo-B trial and the Cardio-TTRansform trial.
